Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sun Yat-sen University
With
The First Affiliated Hospital of Nanchang University
The Affiliated Hospital of Qingdao University
The General Hospital of Eastern Theater Command
Gansu Provincial Hospital
Tang-Du Hospital
Wuhan TongJi Hospital
First Affiliated Hospital of Chongqing Medical University
West China Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shenzhen People's Hospital
The First Affiliated Hospital of Zhengzhou University
Shandong Provincial Hospital
Jiangsu Cancer Institute & Hospital
Guangdong Provincial People's Hospital
Liaoning Cancer Hospital & Institute
Qilu Hospital of Shandong University
Jiangxi Provincial People's Hopital
Sichuan Cancer Hospital and Research Institute
Lanzhou University Second Hospital
Shenzhen Third People's Hospital
Qianfoshan Hospital
Guangxi Nanxishan Hospital
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Age from 18 to 80 years old;
2. Patients with blood pressure\<160/100mmHg, 5.6\<blood glucose\<11.2mmol/L, major organs function normally: (1) Goldman index between grade 1 and 2; (2) Predicted forced expiratory volume in 1s (FEV1) \>= 40 % and diffusing capacity of the lung for carbon monoxide (DLCO) \>= 40 %; (3) total bilirubin \<= 1.5 upper limit of normal; (4) Alanine aminotransferase (ALT)/Aspartate aminotransferase (AST) \<= 2.5 upper limit of normal; (5) creatinine \<= 1.25 upper limit of normal and creatinine clearance rate (CCr) \>= 60ml/min;
3. The first clinical diagnosis before surgery was non-small cell lung cancer, including adenocarcinoma, squamous cell carcinoma, large cell carcinoma, and other unknown types;
4. Clinical stage T1-2N0-1 (cI-II): Maximum diameter of tumor \<= 5cm and short diameter of mediastinal lymph node \<= 1cm in thin layer CT;
5. Performance status of Eastern Cooperative Oncology Group (ECOG) 0-1;
6. All relevant examinations were completed within 28 days before the operation;
7. Patients who understand this study and have signed an approved Informed Consent.
You may not be if
1. Patients with radiotherapy, chemotherapy, targeted therapy, or immunotherapy before surgery.
2. Patients with the previous history of other malignancies;
3. Patients with secondary primary cancer when enrolled;
4. Patients diagnosed as pure ground glass opacity (GGO) before surgery;
5. Patients diagnosed as mixed GGO whose solid part \<= 50% and Maximum diameter of tumor \<= 2cm;
6. Patients with small cell lung cancer;
7. Patients with prior unilateral open thoracic surgical procedures;
8. Woman who is pregnant or breastfeeding;
9. Patients with interstitial pneumonia, pulmonary fibrosis, or severe emphysema;
10. Patients with an active bacterial or fungal infection that is difficult to control;
11. Patients with serious psychosis;
12. Patients with a history of severe heart attack, heart failure, myocardial infarction, or angina within the last 6 months.
Clareo Health | Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
